MR编号 | SE/H/1134/001 |
---|
药品名称 | Acnatac |
---|
活性成分 | - Clindamycin phosphate 1.2 %
- Tretinoin 0.02 %
|
---|
剂型 | Gel |
---|
上市许可持有人 | Viatris AB
Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) Acnex |
---|
互认成员国 - 产品名称 | - Germany (DE)
Acnex - Denmark (DK)
- Belgium (BE)
Treclinax - Netherlands (NL)
Treclinac 0,25 mg/g + 10 mg/g, gel - Luxembourg (LU)
- Iceland (IS)
Acnatac 10 mg/mg + 0,25 mg/g Hlaup - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Acnatac - Lithuania (LT)
Treclinac 10 mg/0,25mg/g gelis - Bulgaria (BG)
Acnex gel - Cyprus (CY)
ZIANA GEL - Czechia (CZ)
Acnex - Romania (RO)
ACNATAC 10 mg/g + 0,25 mg/g gel - Slovakia (SK)
Acnex - Slovenia (SI)
- Malta (MT)
Acnex 10mg/g + 0.25mg/g gel - Latvia (LV)
Treclinac 10 mg/0,25 mg/g gels - Estonia (EE)
TRECLINAC
|
---|
许可日期 | 2013/02/28 |
---|
最近更新日期 | 2024/10/24 |
---|
药物ATC编码 | - D10AF51 clindamycin, combinations
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|